Press Releases - 2023-12-06

Date	Title	Company
06-Dec-2023	bit.bio further expands ioCells™️ range with early access launch of ioMotor Neurons™️ for research and drug discovery in diseases such as amyotrophic lateral sclerosis (ALS)	Businesswire
06-Dec-2023	Catawba Research Partners With Elligo Health Research® to Expand Access and Simplify Clinical Research Participation	Businesswire
06-Dec-2023	Riassunto: Una nuova analisi a posteriori dei dati di fase 3 dimostra come AJOVY® (fremanezumab) consenta di ridurre gli attacchi di emicrania in adulti soggetti ad emicranie e con obesità come comorbilità	Businesswire
06-Dec-2023	Resumen: Un nuevo análisis post hoc de datos de fase 3 muestra que AJOVY® (fremanezumab) redujo los ataques de migraña en adultos con migraña y obesidad comórbida	Businesswire
06-Dec-2023	Dr. Vijay Ivaturi Announced as New Chief Executive Officer at PumasAI	PumasAI
06-Dec-2023	IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated Inflammatory Disease Treatment Research and Development	Businesswire
06-Dec-2023	inTEST Continues Executing on Five-Point Strategy to Expand Geographically - Establishes Southeast Asia Center of Excellence in Malaysia	Businesswire
06-Dec-2023	Riverbed Survey: Ninety-Three Percent of Manufacturing Decision-Makers Believe They Need to Provide More Advanced Digital Experiences to Remain Competitive as Next Generation Employees Enter the Workforce	Businesswire
06-Dec-2023	IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials	Businesswire
06-Dec-2023	TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer	Businesswire
06-Dec-2023	Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer	Businesswire
06-Dec-2023	Empress Therapeutics Appoints Virginia Finnerty-Brooks Chief Business Officer	Businesswire
06-Dec-2023	Delix Presents Interim Data From Phase I Trial of Novel Neuroplastogen at ACNP Annual Meeting	Businesswire
06-Dec-2023	Ionpath Announces Executive Chair Appointment and CEO Promotion	Businesswire
06-Dec-2023	Asia-Pacific Nucleic Acid Therapeutics CDMO Market Report 2023-2033: Continued R&D for Manufacturing Innovative Nucleic Acid Therapeutics Forcing Pharmaceutical Companies to Expand their Businesses - ResearchAndMarkets.com	Businesswire
06-Dec-2023	COP28 Announcement Pushes for More Timber in Construction and More Sustainable Forestry	Businesswire
06-Dec-2023	Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program	Businesswire
06-Dec-2023	Managing Service Providers including CRO (Contract Research Organisation) and CMOs Oversight to comply with ICH GCP (Good Clinical Practice) R3 Training Course - ResearchAndMarkets.com	Businesswire
06-Dec-2023	Global Peptide Therapeutics Markets, Drug Dosage, Price & Clinical Trials Insights, 2029 - ResearchAndMarkets.com	Businesswire
06-Dec-2023	Coya Therapeutics Announces $26.5 Million Private Placement	Businesswire